|
Insider Trading: Boston Scientific Corp
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005.
The reporting company's ticker symbol is BSX.
The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $9,266,225.
The total value of stock sales is $66,905,772.
The total value of stock exercises is $53,963,320.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Boston Scientific Corp (BSX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Boston Scientific Corp (BSX) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Boston Scientific Corp (BSX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 10,000 | 122,300 | 20,000 | 238,200 | 121,427 | 0 |
| 2008-06 | 0 | 0 | 0 | 0 | 104,912 | 0 |
| 2008-05 | 0 | 0 | 0 | 0 | 1,052,148 | 8,973,704 |
| 2008-02 | 5,500 | 67,537 | 0 | 0 | 161,728 | 613,000 |
| 2007-12 | 0 | 0 | 0 | 0 | 56,000 | 581,840 |
| 2007-11 | 0 | 0 | 9,000 | 113,618 | 0 | 0 |
| 2007-10 | 0 | 0 | 56,000 | 780,080 | 56,000 | 581,840 |
| 2007-08 | 15,000 | 196,200 | 93,467 | 1,138,661 | 0 | 0 |
| 2007-07 | 0 | 0 | 0 | 0 | 190,166 | 0 |
| 2007-05 | 0 | 0 | 3,528,850 | 56,727,410 | 2,899,250 | 37,335,399 |
| 2007-04 | 10,000 | 157,750 | 340,000 | 5,404,810 | 348,000 | 4,318,680 |
| 2006-11 | 20,000 | 318,050 | 0 | 0 | 0 | 0 |
| 2006-08 | 25,000 | 405,500 | 0 | 0 | 0 | 0 |
| 2006-05 | 88,000 | 1,859,480 | 116,363 | 2,502,993 | 121,492 | 1,558,857 |
| 2006-04 | 10,000 | 221,700 | 0 | 0 | 0 | 0 |
| 2006-02 | 262,103 | 5,917,708 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Boston Scientific Corp (BSX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-31 | Onuscheck John Michael (SVP & Pres-Neuromodulation) | Option Exercise | 3,118 | .00 | 0 |
| 2008-07-28 | Mcconnell William F Jr (SVP, Administration CRM) | Sale | 20,000 | 11.91 | 238,200 |
| 2008-07-25 | Groves Ray J (Director) | Purchase | 10,000 | 12.23 | 122,300 |
| 2008-07-24 | Gilbert James (EVP) | Option Exercise | 5,017 | .00 | 0 |
| 2008-07-24 | Mcconnell William F Jr (SVP, Administration CRM) | Option Exercise | 9,046 | .00 | 0 |
| 2008-07-10 | Baim Donald S (EVP, Chief Med. & Sci. Officer) | Option Exercise | 16,666 | .00 | 0 |
| 2008-07-01 | Mcfaul David W (Senior VP International) | Option Exercise | 3,280 | .00 | 0 |
| 2008-07-01 | Kucheman William (SVP & Group President) | Option Exercise | 4,300 | .00 | 0 |
| 2008-07-01 | Quinn Lucia Luce (Exec. Vice President-HR) | Option Exercise | 8,000 | .00 | 0 |
| 2008-07-01 | Pucel Kenneth (EVP, Operations) | Option Exercise | 8,000 | .00 | 0 |
| 2008-07-01 | Burns Brian R (SVP - Quality) | Option Exercise | 8,000 | .00 | 0 |
| 2008-07-01 | Gilbert James (EVP) | Option Exercise | 8,000 | .00 | 0 |
| 2008-07-01 | Paul Donovan (SVP, Corporate Comm) | Option Exercise | 8,000 | .00 | 0 |
| 2008-07-01 | Laviolette Paul A (COO) | Option Exercise | 20,000 | .00 | 0 |
| 2008-07-01 | Burns Ursula M (Director) | Option Exercise | 4,000 | .00 | 0 |
| 2008-07-01 | Colen Fred (President, CRM) | Option Exercise | 8,000 | .00 | 0 |
| 2008-07-01 | Moreci Stephen F (Sr. VP, Endosurgery) | Option Exercise | 8,000 | .00 | 0 |
| 2008-06-20 | Mcfaul David W (Senior VP International) | Option Exercise | 4,912 | .00 | 0 |
| 2008-06-05 | Leno Sam R (CFO & EVP Finance & IS) | Option Exercise | 100,000 | .00 | 0 |
| 2008-05-31 | Quinn Lucia Luce (Exec. Vice President-HR) | Option Exercise | 10,000 | .00 | 0 |
| 2008-05-17 | Quinn Lucia Luce (Exec. Vice President-HR) | Option Exercise | 1,375 | .00 | 0 |
| 2008-05-17 | Gilbert James (EVP) | Option Exercise | 5,450 | .00 | 0 |
| 2008-05-17 | Paul Donovan (SVP, Corporate Comm) | Option Exercise | 2,200 | .00 | 0 |
| 2008-05-08 | Mcfaul David W (Senior VP International) | Option Exercise | 875 | .00 | 0 |
| 2008-05-08 | Mcconnell William F Jr (SVP, Administration CRM) | Option Exercise | 18,575 | .00 | 0 |
| 2008-05-08 | Colen Fred (EVP) | Option Exercise | 11,375 | .00 | 0 |
| 2008-05-07 | Gilbert James (EVP) | Option Exercise | 7,798 | .00 | 0 |
| 2008-05-01 | Nicholas Peter M (Director) | Option Exercise | 994,500 | 9.02 | 8,973,704 |
| 2008-02-29 | Sandman Paul W (EVP and General Counsel) | Option Exercise | 40,700 | .00 | 0 |
| 2008-02-13 | Baim Donald S (EVP, Chief Med. & Sci. Officer) | Option Exercise | 10,514 | .00 | 0 |
| 2008-02-13 | Mcconnell William F Jr (SVP, Administration CRM) | Option Exercise | 10,514 | .00 | 0 |
| 2008-02-08 | Fleishman Joel Lawrence (Director) | Purchase | 5,500 | 12.28 | 67,537 |
| 2008-02-07 | Tobin James R (President & CEO) | Option Exercise | 100,000 | 6.13 | 613,000 |
| 2007-12-18 | Nicholas Peter M (Director) | Option Exercise | 56,000 | 10.39 | 581,840 |
| 2007-11-29 | Reinhardt Uwe E (Director) | Sale | 9,000 | 12.62 | 113,618 |
| 2007-10-31 | Laviolette Paul A (COO) | Sale | 56,000 | 13.93 | 780,080 |
| 2007-10-31 | Laviolette Paul A (COO) | Option Exercise | 56,000 | 10.39 | 581,840 |
| 2007-08-21 | Mario Ernest (Director) | Sale | 93,467 | 12.18 | 1,138,661 |
| 2007-08-13 | Nicholas Nj Jr (Director) | Purchase | 15,000 | 13.08 | 196,200 |
| 2007-07-10 | Baim Donald S (Chief Med. & Sci. Officer) | Option Exercise | 16,666 | .00 | 0 |
| 2007-07-06 | Best Lawrence C (EVP) | Option Exercise | 67,200 | .00 | 0 |
| 2007-07-01 | Kucheman William (SVP & Group President) | Option Exercise | 4,300 | .00 | 0 |
| 2007-07-01 | Quinn Lucia Luce (Exec. Vice President-HR) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Pucel Kenneth (EVP, Operations) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Burns Brian R (SVP - Quality) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Gilbert James (EVP) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Goodman Jeffrey H (SVP, International) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Paul Donovan (SVP, Corporate Comm) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Sandman Paul W (EVP and General Counsel) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Laviolette Paul A (COO) | Option Exercise | 20,000 | .00 | 0 |
| 2007-07-01 | Best Lawrence C (EVP) | Option Exercise | 10,000 | .00 | 0 |
| 2007-07-01 | Colen Fred (EVP & Chief Tech. Officer) | Option Exercise | 8,000 | .00 | 0 |
| 2007-07-01 | Moreci Stephen F (Sr. VP, Endosurgery) | Option Exercise | 8,000 | .00 | 0 |
| 2007-05-31 | Quinn Lucia Luce (Exec. Vice President-HR) | Option Exercise | 10,000 | .00 | 0 |
| 2007-05-25 | Bartell Mark C (SVP Global Sales/Mkt CRM) | Sale | 828,250 | 15.75 | 13,044,882 |
| 2007-05-25 | Bartell Mark C (SVP Global Sales/Mkt CRM) | Option Exercise | 828,250 | 14.20 | 11,758,389 |
| 2007-05-07 | Nicholas Peter M (Director) | Sale | 14,300 | 16.61 | 237,575 |
| 2007-05-07 | Abele John E (Director) | Sale | 2,000 | 16.58 | 33,163 |
| 2007-05-04 | Nicholas Peter M (Director) | Sale | 813,000 | 16.22 | 13,189,805 |
| 2007-05-04 | Nicholas Peter M (Director) | Option Exercise | 960,000 | 12.41 | 11,913,600 |
| 2007-05-04 | Abele John E (Director) | Sale | 151,000 | 16.22 | 2,449,766 |
| 2007-05-04 | Abele John E (Director) | Option Exercise | 181,000 | 12.41 | 2,246,210 |
| 2007-05-03 | Best Lawrence C (EVP and CFO) | Sale | 300,000 | 16.26 | 4,881,503 |
| 2007-05-03 | Best Lawrence C (EVP and CFO) | Option Exercise | 300,000 | 12.41 | 3,723,000 |
| 2007-05-02 | Best Lawrence C (EVP and CFO) | Sale | 300,000 | 16.17 | 4,854,267 |
| 2007-05-02 | Best Lawrence C (EVP and CFO) | Option Exercise | 300,000 | 12.41 | 3,723,000 |
| 2007-05-01 | Sandman Paul W (EVP and General Counsel) | Sale | 320,000 | 15.80 | 5,057,107 |
| 2007-05-01 | Sandman Paul W (EVP and General Counsel) | Option Exercise | 320,000 | 12.41 | 3,971,200 |
| 2007-04-30 | Nicholas Nj Jr (Director) | Purchase | 10,000 | 15.78 | 157,750 |
| 2007-04-26 | Laviolette Paul A (COO) | Sale | 340,000 | 15.90 | 5,404,810 |
| 2007-04-26 | Laviolette Paul A (COO) | Option Exercise | 340,000 | 12.41 | 4,219,400 |
| 2007-04-26 | Fleishman Joel Lawrence (Director) | Option Exercise | 8,000 | 12.41 | 99,280 |
| 2006-11-14 | Nicholas Nicholas J Jr (Director) | Purchase | 5,000 | 15.52 | 77,600 |
| 2006-11-02 | Nicholas Nicholas J Jr (Director) | Purchase | 15,000 | 16.03 | 240,450 |
| 2006-08-03 | Nicholas Nicholas J Jr (Director) | Purchase | 25,000 | 16.22 | 405,500 |
| 2006-05-31 | Quinn Lucia Luce (Exec. Vice President-HR) | Option Exercise | 10,000 | .00 | 0 |
| 2006-05-31 | Johnson Kristina M (Director) | Sale | 24,000 | 20.42 | 490,158 |
| 2006-05-31 | Johnson Kristina M (Director) | Option Exercise | 24,000 | 16.46 | 395,040 |
| 2006-05-23 | Nicholas Nicholas J Jr (Director) | Purchase | 10,000 | 19.45 | 194,500 |
| 2006-05-17 | Burns Ursula M (Director) | Purchase | 3,000 | 20.70 | 62,100 |
| 2006-05-16 | Goodman Jeffrey H (SVP-International) | Purchase | 3,500 | 20.60 | 72,100 |
| 2006-05-15 | Goodman Jeffrey H (SVP-International) | Purchase | 1,500 | 20.32 | 30,480 |
| 2006-05-10 | Nicholas Nicholas J Jr (Director) | Purchase | 10,000 | 21.39 | 213,900 |
| 2006-05-10 | Mario Ernest (Director) | Purchase | 50,000 | 21.34 | 1,066,750 |
| 2006-05-04 | Deparle Nancy Ann (Director) | Sale | 2,553 | 21.91 | 55,936 |
| 2006-05-03 | Nicholas Nicholas J Jr (Director) | Purchase | 5,000 | 21.87 | 109,350 |
| 2006-05-03 | Deparle Nancy Ann (Director) | Sale | 77,810 | 22.00 | 1,711,820 |
| 2006-05-03 | Deparle Nancy Ann (Director) | Option Exercise | 75,492 | 12.80 | 966,297 |
| 2006-05-02 | Nicholas Nicholas J Jr (Director) | Purchase | 5,000 | 22.06 | 110,300 |
| 2006-04-24 | Nicholas Nicholas J Jr (Director) | Purchase | 10,000 | 22.17 | 221,700 |
| 2006-02-28 | Reinhardt Uwe E (Director) | Purchase | 5,000 | 24.45 | 122,250 |
| 2006-02-28 | Pepper John E (Director) | Purchase | 15,000 | 24.45 | 366,750 |
| 2006-02-21 | Moreci Stephen F (Sr. VP, Endosurgery) | Purchase | 4,103 | 24.37 | 99,990 |
| 2006-02-16 | Burns Ursula M (Director) | Purchase | 3,000 | 24.31 | 72,930 |
| 2006-02-15 | Best Lawrence C (SVP and CFO) | Purchase | 200,000 | 22.43 | 4,486,222 |
| 2006-02-13 | Nicholas Nicholas J Jr (Director) | Purchase | 15,000 | 21.88 | 328,300 |
| 2006-02-09 | Nicholas Nicholas J Jr (Director) | Purchase | 10,000 | 22.24 | 222,366 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Boston Scientific Corp (symbol BSX,
CIK number 885725) see
the Securities and Exchange Commission (SEC) website.
|
|
